Uncommon clinical manifestations of cutaneous leishmaniasis;Außergewöhnliche klinische Manifestationen der kutanen Leishmaniasis

Hautarzt

Volumn 65, Issue 10, 2014, Pages 889-894

  Hayani, K ^a   Dandashli, A ^b   Weisshaar, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Saudi German Hospital ^*  (United Arab Emirates)

Author keywords

Aleppo boil; Epidemiology; Meglumine antimonite; Sandflies; Tropical dermatology

Indexed keywords

ARTICLE; CLINICAL FEATURE; HUMAN; MEDICAL CARE; MEDICAL DOCUMENTATION; PSYCHODIDAE; SKIN LEISHMANIASIS; SYRIAN; EPIDEMIC; INCIDENCE; LEISHMANIASIS, CUTANEOUS; RARE DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SYRIAN ARAB REPUBLIC; TROPIC CLIMATE;

DISEASE OUTBREAKS; HUMANS; INCIDENCE; LEISHMANIASIS, CUTANEOUS; RARE DISEASES; RISK FACTORS; SYRIA; TROPICAL CLIMATE;

EID: 84910610931     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-014-2802-7     Document Type: Article

References (33)

1. Elgood C (1934) The early history of the Baghdad boil. J R Asiat Soc 3:519–533
2. Russel A (1756) The Natural History of Aleppo. A. Millar, London, S 262–266
3. Jallad M (1989) Zoonotic and parasitic diseases in Syria. Proceedings of the 3rd Intl. and Pan-Arab Seminar. Amman, Jordanien, S 59–64
4. Desjeux P (1991) Information on the epidemiology and control of the Leishmaniases by country or territory. World Health Organization, Switzerland, WHO/LEISH/91.30, S 29
5. Ashford RW, Rioux JA, Jalouk L et al (1993) Evidence for a long-term increase in the incidence of Leishmania tropica in Aleppo, Syria. Trans R Soc Trop Med Hyg 87(3):247–249
6. Tayeh A, Lama J, Cairncross S (1997) Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg 91(6):657–659
7. Annonymous (2010) WHO Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. S 91–96
8. Alvar J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671
9. Al-Nahhas S, Shabaan M, Hammoud L et al (2003) Visceral leishmaniasis in the Syrian Arab Republic: early detection using rK39. East Mediterr Health J 9(4):856–862
10. Belazzoug S et al (1988) Un nouveau zymodeme de Leishmania tropica, agent du Bouton d’Alep (Syrie). Arch Inst Pasteur Alger 56:95–99
11. Khiami A, Dereure J, Pratlong F et al (1991) La leishmaniose cutane humaine à Leishmania major MON-26 aux environs de Damas (Syrie). Bull Soc Exp Pathol 84:340–344
12. Knio KN, Baydoun E, Tawk R, Nuwayri-Salti N (2000) Isoenzyme characterization of Leishmania isolates from Lebanon and Syria. Am J Trop Med Hyg 63(1–2):43–47
13. Rioux JA, Lanotte G (1990) Leishmania infantum as a cause of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 84(6):898
14. World Health Organization (2010) Control of the leishmaniases. World Health Organization Technical Report Series. 949:xii–xiii, 1–186 (back cover)
15. Adler S, Theodor O (1929) The distribution of sandflies of the erected-haired group in relation to oriental sore. Ann Trop Med Parasitol 23:269–302
16. Adler S, Theodor O (1928) The presence of phlebotomus chinensis in Syria. Nature 12:572–573
17. Stebut E von, Schleicher U, Bogdan C (2012) Cutaneous leishmaniasis as travelers‘ disease. Clinical presentation, diagnostics and therapy. Hautarzt 63(3):233–246
18. Pratlong F et al (2009) Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains. Trop Med Int Health 14(9):1071–1085
19. Yanık M et al (2004) The psychological impact of cutaneous leishmaniasis. Clin Exp Dermatol 29:464–467
20. Rehor GE et al (2010) Cheilitis granulomatosa als Erstmanifestation eines M. Crohn. Hautarzt 61:691–693
21. Saalmann R et al (2009) Orofacial granulomatosis in childhood – a clinical entity that may indicate Crohn’s disease as well as food allergy. Acta Paediatr 98:1162–1167
22. Abazid N et al (2012) Knowledge, attitudes and practices about leishmaniasis among cutaneous leishmaniasis patients in Aleppo, Syrian Arab Republic. East Mediterr Health J 18(1):7–14
23. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27(5):305–318
24. Boecken G et al (2011) Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany. J Dtsch Dermatol Ges 9(Suppl 8):1–51
25. Bailey MS et al (2005) Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel. J R Army Med Corps 151:73–80
26. Douba M, Mowakeh A, Wali A (1997) Current status of cutaneous leishmaniasis in Aleppo, Syrian Arab Republic. Bull World Health Organ 75(3):253–259
27. Harms G, Chehade AK, Douba M et al (1991) A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 85(2):214–216
28. Blum J, Desjeux P, Schwartz E et al (2004) Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53:158–166
29. Mujtaba G, Khalid M (1999) Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis. Int J Dermatol 38:607–609
30. Wortmann G, Miller RS, Oster C et al (2002) A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis 35(3):261–267
31. Seeberger J, Daoud S, Pammer J (2003) Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod. Int J Dermatol 42:576–579
32. Al-Wakeel M et al (1997) Cutaneous leishmaniasis (Aleppo boil): successful treatment with topical paromomycin. Eur J Dermatol 7:47–48
33. WHO warns of increased risk of disease epidemics in Syria and in neighbouring countries as summer approaches, 3 June 2013. http://www.emro.who.int/press-releases/2013/disease-epidemics-syria.html